1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Op De Beeck, A.
Montserret, R.
Duvet, S.
Cocquerel, L.
Cacan, R.
Barberot, B.
Le Maire, M.
Penin, F.
Dubuisson, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
275
31428
31437
10.1074/jbc.M003003200
10807921
The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization.
2000
10.2210/pdb1emz/pdb
pdb_00001emz
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2237.581
ENVELOPE GLYCOPROTEIN E1
TRANSMEMBRANE DOMAIN (RESIDUES 350-370)
1
syn
polymer
no
no
GAHWGVLAGIAYFSMVGNWAK
GAHWGVLAGIAYFSMVGNWAK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2000-04-05
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
RCSB
Y
RCSB
2000-03-20
REL
REL
This peptide was chemically synthesized. The sequence of this peptide is naturally found in hepatitis C virus.
sample
sodium 2,2 dimethyl-2-silapentane-5-sulfonate (DSS) in the internal nmr reference
back calculated data agree with experimental NOESY spectrum,structures with the least restraint violations,structures with the lowest energy
50
1
DQF-COSY
TOCSY
2D NOESY
5.7
ambient
293
K
the structure is based on 337 Noe derived distance constraints
distance geometry, simulated annealing, molecular dynamic, energy minimization
1
closest to the average
4 mM E1(350-370), 50% H2O, 50% D2 trifluoroethanol (v/v)
50% H2O, 50% D2 trifluoroethanol (v/v)
Varian Inc.
collection
VNMR
6.1
Brunger A.T.
structure solution
X-PLOR
3.1
Brunger A.T.
refinement
X-PLOR
3.1
500
Varian
UNITYPLUS
GLY
1
n
1
GLY
1
A
ALA
2
n
2
ALA
2
A
HIS
3
n
3
HIS
3
A
TRP
4
n
4
TRP
4
A
GLY
5
n
5
GLY
5
A
VAL
6
n
6
VAL
6
A
LEU
7
n
7
LEU
7
A
ALA
8
n
8
ALA
8
A
GLY
9
n
9
GLY
9
A
ILE
10
n
10
ILE
10
A
ALA
11
n
11
ALA
11
A
TYR
12
n
12
TYR
12
A
PHE
13
n
13
PHE
13
A
SER
14
n
14
SER
14
A
MET
15
n
15
MET
15
A
VAL
16
n
16
VAL
16
A
GLY
17
n
17
GLY
17
A
ASN
18
n
18
ASN
18
A
TRP
19
n
19
TRP
19
A
ALA
20
n
20
ALA
20
A
LYS
21
n
21
LYS
21
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
SOLUTION STRUCTURE OF FRAGMENT (350-370) OF THE TRANSMEMBRANE DOMAIN OF HEPATITIS C ENVELOPE GLYCOPROTEIN E1
1
N
N
A
HIS
3
A
HIS
3
HELX_P
A
LYS
21
A
LYS
21
1
1
19
VIRAL PROTEIN
transmembrane domain, envelope protein E1, hepatitis C virus, Viral protein
Q9Q3N3_9HEPC
UNP
1
350
Q9Q3N3
GAHWGVLAGIAYFSMVGNWAK
350
370
1EMZ
1
21
Q9Q3N3
A
1
1
21
1
P 1